Co-founder, CEO

Jessica draws on 10 years of clinical trial experience with cancer patients. Jessica holds a Masters in Clinical Neuroscience from Vanderbilt University and her academic research focused on the impact of stress on brain development. Jessica’s interests in artificial intelligence have been pervasive across her career and continued education at MIT which led to the formation of her company Athelo with Monica Schmiede. Additionally, Jessica and her strategic team were winners in 2018 of the Clinical Researcher of the Year competition for their app design. She was the recipient of 6 national awards for her academic research on how stress impacts brain development. During her 10+ years working in cancer care and infectious disease, Jessica has managed more than 75 clinical trials and budgets upwards of $75M across sites, CROs and the biotech space. She is a passionate innovator, entrepreneur, activist and feminist.

Co-founder, Chief Business Officer

Prior to Athelo, she led business development for the West Coast developing clinical trial partnerships for early-stage oncology assets for Caidya (formerly known as Clinipace), a mid-sized contract research organization. During this time, she successfully grew revenue by 30% leading to the company’s subsequent acquisition. She has held leadership roles at Informa Pharma Intelligence managing commercial licensing for drug development intelligence platforms across biotechnology and large pharmaceutical customers. She holds a Masters in Business from the London School of Economics and Bachelors in Environmental Policy from Rutgers University. Monica is an avid freediver with German and Polish fluency. She resides in Northern California with her partner, cats, dogs, bees and chickens.